170 related articles for article (PubMed ID: 28302509)
1. Binding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulation.
Wang H; Zaidi SA; Zhang Y
Bioorg Med Chem; 2017 Apr; 25(8):2463-2471. PubMed ID: 28302509
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Biological Evaluation of the Third Generation 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan (NAP) Derivatives as μ/κ Opioid Receptor Dual Selective Ligands.
Zheng Y; Obeng S; Wang H; Jali AM; Peddibhotla B; Williams DA; Zou C; Stevens DL; Dewey WL; Akbarali HI; Selley DE; Zhang Y
J Med Chem; 2019 Jan; 62(2):561-574. PubMed ID: 30608693
[TBL] [Abstract][Full Text] [Related]
3. Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: application of the 'message-address' concept in development of mu opioid receptor selective antagonists.
Zaidi SA; Arnatt CK; He H; Selley DE; Mosier PD; Kellogg GE; Zhang Y
Bioorg Med Chem; 2013 Nov; 21(21):6405-13. PubMed ID: 24055076
[TBL] [Abstract][Full Text] [Related]
4. Structure selectivity relationship studies of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[(4'-pyridyl)carboxamido]morphinan derivatives toward the development of the mu opioid receptor antagonists.
Yuan Y; Elbegdorj O; Chen J; Akubathini SK; Beletskaya IO; Selley DE; Zhang Y
Bioorg Med Chem Lett; 2011 Sep; 21(18):5625-9. PubMed ID: 21788135
[TBL] [Abstract][Full Text] [Related]
5. 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion.
Zhang Y; Williams DA; Zaidi SA; Yuan Y; Braithwaite A; Bilsky EJ; Dewey WL; Akbarali HI; Streicher JM; Selley DE
ACS Chem Neurosci; 2016 Mar; 7(3):297-304. PubMed ID: 26716358
[TBL] [Abstract][Full Text] [Related]
6. Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan analogues as opioid receptor ligands.
Yuan Y; Zaidi SA; Stevens DL; Scoggins KL; Mosier PD; Kellogg GE; Dewey WL; Selley DE; Zhang Y
Bioorg Med Chem; 2015 Apr; 23(8):1701-15. PubMed ID: 25783191
[TBL] [Abstract][Full Text] [Related]
7. Computational insights into the molecular mechanisms of differentiated allosteric modulation at the mu opioid receptor by structurally similar bitopic modulators.
Wang H; Reinecke BA; Zhang Y
J Comput Aided Mol Des; 2020 Aug; 34(8):879-895. PubMed ID: 32193867
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, pharmacological evaluation and molecular dynamics of β-amino acids morphan-derivatives as novel ligands for opioid receptors.
Nieto CT; Gonzalez-Nunez V; Rodríguez RE; Diez D; Garrido NM
Eur J Med Chem; 2015 Aug; 101():150-62. PubMed ID: 26134550
[TBL] [Abstract][Full Text] [Related]
9. Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis.
Lipiński PFJ; Kosson P; Matalińska J; Roszkowski P; Czarnocki Z; Jarończyk M; Misicka A; Dobrowolski JC; Sadlej J
Molecules; 2019 Feb; 24(4):. PubMed ID: 30791394
[TBL] [Abstract][Full Text] [Related]
10. Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands.
Xu H; Lu YF; Partilla JS; Zheng QX; Wang JB; Brine GA; Carroll FI; Rice KC; Chen KX; Chi ZQ; Rothman RB
Synapse; 1999 Apr; 32(1):23-8. PubMed ID: 10188634
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of N-phenylalkyl-substituted tramadol derivatives as novel μ opioid receptor ligands.
Shen Q; Qian YY; Xu XJ; Li W; Liu JG; Fu W
Acta Pharmacol Sin; 2015 Jul; 36(7):887-94. PubMed ID: 26051109
[TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.
Peng Y; Keenan SM; Zhang Q; Kholodovych V; Welsh WJ
J Med Chem; 2005 Mar; 48(5):1620-9. PubMed ID: 15743203
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
14. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
[TBL] [Abstract][Full Text] [Related]
15. Structural comparison of mu-opioid receptor selective peptides confirmed four parameters of bioactivity.
Borics A; Tóth G
J Mol Graph Model; 2010 Feb; 28(6):495-505. PubMed ID: 20036591
[TBL] [Abstract][Full Text] [Related]
16. A Blocking Group Scan Using a Spherical Organometallic Complex Identifies an Unprecedented Binding Mode with Potent Activity In Vitro and In Vivo for the Opioid Peptide Dermorphin.
Strack M; Bedini A; Yip KT; Lombardi S; Siegmund D; Stoll R; Spampinato SM; Metzler-Nolte N
Chemistry; 2016 Oct; 22(41):14605-10. PubMed ID: 27553294
[TBL] [Abstract][Full Text] [Related]
17. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
Watson B; Meng F; Akil H
Neurobiol Dis; 1996 Feb; 3(1):87-96. PubMed ID: 9173916
[TBL] [Abstract][Full Text] [Related]
18. Molecular Docking, Molecular Dynamics, and Structure-Activity Relationship Explorations of 14-Oxygenated N-Methylmorphinan-6-ones as Potent μ-Opioid Receptor Agonists.
Noha SM; Schmidhammer H; Spetea M
ACS Chem Neurosci; 2017 Jun; 8(6):1327-1337. PubMed ID: 28125215
[TBL] [Abstract][Full Text] [Related]
19. Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid receptor ligands.
Calderon SN; Rice KC; Rothman RB; Porreca F; Flippen-Anderson JL; Kayakiri H; Xu H; Becketts K; Smith LE; Bilsky EJ; Davis P; Horvath R
J Med Chem; 1997 Feb; 40(5):695-704. PubMed ID: 9057856
[TBL] [Abstract][Full Text] [Related]
20. Novel Dual-Target μ-Opioid Receptor and Dopamine D
Bonifazi A; Battiti FO; Sanchez J; Zaidi SA; Bow E; Makarova M; Cao J; Shaik AB; Sulima A; Rice KC; Katritch V; Canals M; Lane JR; Newman AH
J Med Chem; 2021 Jun; 64(11):7778-7808. PubMed ID: 34011153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
